Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis

ClinicalTrials.gov ID: NCT03825315

Public ClinicalTrials.gov record NCT03825315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 12:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Prospective, Randomized, Double-Blind, Multi-center, Placebo-Controlled Trial of DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of a single administration of DaxibotulinumtoxinA (DAXI) (high-dose; low-dose) for injection versus placebo for the management of Plantar Fasciitis.

Study identification

NCT ID
NCT03825315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Revance Therapeutics, Inc.
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 30, 2018
Primary completion
Jun 3, 2020
Completion
Jun 3, 2020
Last update posted
Sep 20, 2023

2018 – 2020

United States locations

U.S. sites
20
U.S. states
9
U.S. cities
18
Facility City State ZIP Site status
Aung Foot Health Clinic Tucson Arizona 85710
Sacramento Foot and Ankle Center, Inc Carmichael California 95608
Bay Area Foot Care Castro Valley California 94546
West Coast Foot and Ankle Huntington Beach California 92648
Foot and Ankle Clinic Los Angeles California 90057
Bay Area Foot Care San Francisco California 94115
University Foot and Ankle Foundation Santa Monica California 90403
LA Podiatry Group West Palm Beach Florida 33406
Podiatry 1st Belleville Illinois 62226
Rosalind Franklin University of Medicine & Science North Chicago Illinois 60064
Kansas Institute of Research Overland Park Kansas 66211-1358
Advanced Foot & Ankle Center Las Vegas Nevada 89119
Medical Research International Oklahoma City Oklahoma 73109
North Texas Institute of Neurology and Headache Frisco Texas 75034
Hermann Drive Research Hospital Houston Texas 77004
Futuro Clinical Trials, LLC McAllen Texas 78501
Strash Foot and Ankle Care San Antonio Texas 78209
The Podiatry Group of South Texas San Antonio Texas 78295
Rocky Mountain Foot and Ankle, LLC Salt Lake City Utah 84107
Wasatch Clinical Research Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03825315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2023 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03825315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →